Herold II ITN007AI: Treatment with hOKT3-gamma-1 (Ala-Ala) in Type 1 Diabetes Mellitus
收藏官方服务：
资源简介：
This is a phase II study examining clinical and immunological effects of humanized FcR non-binding anti-CD3 mAb in participants with Type 1 diabetes mellitus (T1DM), and to develop this therapy to prevent immune destruction leading to beta cell loss.
提供机构：
ImmPort创建时间：
2015-06-19
